Literature DB >> 27296809

Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes.

R Ryanne Wu1,2, Rachel A Myers3, Elizabeth R Hauser4,5,6, Allison Vorderstrasse3,7, Alex Cho3,4, Geoffrey S Ginsburg3,4,8, Lori A Orlando3,4.   

Abstract

Family health history (FHH) in the context of risk assessment has been shown to positively impact risk perception and behavior change. The added value of genetic risk testing is less certain. The aim of this study was to determine the impact of Type 2 Diabetes (T2D) FHH and genetic risk counseling on behavior and its cognitive precursors. Subjects were non-diabetic patients randomized to counseling that included FHH +/- T2D genetic testing. Measurements included weight, BMI, fasting glucose at baseline and 12 months and behavioral and cognitive precursor (T2D risk perception and control over disease development) surveys at baseline, 3, and 12 months. 391 subjects enrolled of which 312 completed the study. Behavioral and clinical outcomes did not differ across FHH or genetic risk but cognitive precursors did. Higher FHH risk was associated with a stronger perceived T2D risk (pKendall < 0.001) and with a perception of "serious" risk (pKendall < 0.001). Genetic risk did not influence risk perception, but was correlated with an increase in perception of "serious" risk for moderate (pKendall = 0.04) and average FHH risk subjects (pKendall = 0.01), though not for the high FHH risk group. Perceived control over T2D risk was high and not affected by FHH or genetic risk. FHH appears to have a strong impact on cognitive precursors of behavior change, suggesting it could be leveraged to enhance risk counseling, particularly when lifestyle change is desirable. Genetic risk was able to alter perceptions about the seriousness of T2D risk in those with moderate and average FHH risk, suggesting that FHH could be used to selectively identify individuals who may benefit from genetic risk testing.

Entities:  

Keywords:  Family history; Genetic testing; Primary prevention; Risk stratification

Mesh:

Year:  2016        PMID: 27296809     DOI: 10.1007/s10897-016-9988-z

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  25 in total

1.  Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research.

Authors:  Theresa M Marteau; John Weinman
Journal:  Soc Sci Med       Date:  2005-09-12       Impact factor: 4.634

2.  Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination.

Authors:  Noel T Brewer; Gretchen B Chapman; Frederick X Gibbons; Meg Gerrard; Kevin D McCaul; Neil D Weinstein
Journal:  Health Psychol       Date:  2007-03       Impact factor: 4.267

3.  Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention.

Authors:  A M Codori; G M Petersen; D L Miglioretti; P Boyd
Journal:  Prev Med       Date:  2001-08       Impact factor: 4.018

Review 4.  The effectiveness of one-to-one risk communication interventions in health care: a systematic review.

Authors:  A Edwards; K Hood; E Matthews; D Russell; I Russell; J Barker; M Bloor; P Burnard; J Covey; R Pill; C Wilkinson; N Stott
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

5.  Family breast cancer history and mammography: Framingham Offspring Study.

Authors:  J M Murabito; J C Evans; M G Larson; B E Kreger; G L Splansky; K M Freund; M A Moskowitz; P W Wilson
Journal:  Am J Epidemiol       Date:  2001-11-15       Impact factor: 4.897

6.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

Review 7.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

Authors:  Theresa M Marteau; David P French; Simon J Griffin; A T Prevost; Stephen Sutton; Clare Watkinson; Sophie Attwood; Gareth J Hollands
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

8.  Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.

Authors:  Jose M de Miguel-Yanes; Peter Shrader; Michael J Pencina; Caroline S Fox; Alisa K Manning; Richard W Grant; Josèe Dupuis; Jose C Florez; Ralph B D'Agostino; L Adrienne Cupples; James B Meigs
Journal:  Diabetes Care       Date:  2010-10-01       Impact factor: 19.112

9.  Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

Authors:  Alex H Cho; Ley A Killeya-Jones; Julianne M O'Daniel; Kensaku Kawamoto; Patrick Gallagher; Susanne Haga; Joseph E Lucas; Gloria M Trujillo; Scott V Joy; Geoffrey S Ginsburg
Journal:  BMC Health Serv Res       Date:  2012-01-18       Impact factor: 2.655

10.  Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002.

Authors:  Ann M Annis; Mark S Caulder; Michelle L Cook; Debra Duquette
Journal:  Prev Chronic Dis       Date:  2005-03-15       Impact factor: 2.830

View more
  5 in total

Review 1.  Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.

Authors:  Alex T Ramsey; Li-Shiun Chen; Sarah M Hartz; Nancy L Saccone; Sherri L Fisher; Enola K Proctor; Laura J Bierut
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

2.  Heart disease risk information, encouragement, and physical activity among Mexican-origin couples: Self- or spouse-driven change?

Authors:  Kaley F Skapinsky; Susan Persky; Megan Lewis; Andrea Goergen; Sato Ashida; Hendrik D de Heer; Donald Hadley; Anna V Wilkinson; Laura M Koehly
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

Review 3.  Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.

Authors:  Jyothsna Giri; Ann M Moyer; Suzette J Bielinski; Pedro J Caraballo
Journal:  Pharmgenomics Pers Med       Date:  2019-10-30

4.  A Novel Gene CDC27 Causes SLE and Is Associated With the Disease Activity.

Authors:  Shunlai Shang; Yena Zhou; Keng Chen; Lang Chen; Ping Li; Diangeng Li; Shaoyuan Cui; Mei-Jun Zhang; Xiangmei Chen; Qinggang Li
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

5.  Association between Organophosphate Pesticide Exposure and Insulin Resistance in Pesticide Sprayers and Nonfarmworkers.

Authors:  Mathuramat Seesen; Roberto G Lucchini; Somkiat Siriruttanapruk; Ratana Sapbamrer; Surat Hongsibsong; Susan Woskie; Pornpimol Kongtip
Journal:  Int J Environ Res Public Health       Date:  2020-11-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.